GlassScriptPhysician profile
Jacob Archutowski
NPI 1851033112
$8,982.48
in general payments reported to CMS, 2019-2025
12 companies · $1,200 in 2025
The $1,200 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $3,997 · 2023: $529 · 2024: $3,257 · 2025: $1,200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,909 · Travel and Lodging: $1,077.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,908.50 |
| Travel and Lodging | $1,077.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $3,812.41 | 2022-2025 | |
| Medical Device Business Services, INC. | $1,773.06 | 2024 | Actis |
| Stryker Corporation | $1,106.10 | 2022-2025 | Blueprint Patient Specific Instrumentation, Gamma, Aequalis Ascend Flex |
| Zimmer Biomet Holdings, INC. | $737.66 | 2024-2025 | Persona, Oxford, Juggerknotless Soft Anchor |
| Depuy Synthes Sales INC. | $468.14 | 2024 | Na |
| Avanos Medical | $315.32 | 2023-2024 | On-Q* Pump and Accessories |
| Kci USA, INC. | $191.16 | 2022-2023 | V.A.C. Veraflo |
| Catalyst Orthoscience | $146.38 | 2025 | |
| Si-Bone, INC. | $134.45 | 2024 | |
| Heron Therapeutics, INC. | $121.35 | 2024 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $118.42 | 2022 | |
| Ethicon US, LLC | $58.03 | 2025 | Surgiflo Hemostatic Matrix, Ethicon, Megadyne |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Archutowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.